(CI) Cigna - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1255231003

CI: Health, Pharmacy, Medicare, Dental, Insurance

Cigna Group, operating under the ticker symbol CI on the NYSE, is a prominent player in the health care services sector. As a multinational corporation founded in 1792 and headquartered in Bloomfield, Connecticut, Cigna specializes in providing a diverse array of insurance products and services. The company rebranded from Cigna Corporation to The Cigna Group in February 2023, reflecting its expanded scope and evolution in the health care industry.

Cignas operations are divided into two primary segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment offers a comprehensive suite of health services, including pharmacy benefits management, home delivery pharmacy services, specialty pharmacy offerings, distribution solutions, and care delivery and management services. These services are tailored to meet the needs of health plans, employers, government organizations, and health care providers, ensuring a coordinated approach to health management.

The Cigna Healthcare segment provides an extensive range of medical, pharmacy, behavioral health, and dental services. This segment also offers Medicare Advantage, Medicare Supplement, and Medicare Part D plans designed for seniors, as well as individual health insurance plans. Additionally, Cigna extends its coverage internationally, catering to mobile individuals and employees of multinational organizations, thus providing global health care benefits. The company also offers permanent insurance contracts and stop loss insurance, enhancing its product portfolio.

Cigna distributes its products and services through multiple channels, including insurance brokers and consultants, direct sales to employers, unions, groups, and individuals, as well as through private and public exchanges. This multifaceted approach ensures broad market reach and accessibility to a diverse customer base.

3-Month Forecast:

Based on the provided data, Cigna Corp (NYSE:CI) is expected to show continued growth. The stock is currently trading above its 20-day, 50-day, and 200-day moving averages, indicating a bullish trend. The average true range (ATR) of 8.98 suggests moderate volatility, so price fluctuations within this range are anticipated. The stock may consolidate or trend upwards, with potential support at the 20-day SMA (325.09) and resistance at recent highs (340.00).

From a fundamental perspective, Cignas forward P/E of 11.42 indicates expectations of earnings growth, despite the current P/E of 27.92. The price-to-sales ratio of 0.37 suggests the stock may be undervalued relative to its revenue. The return on equity (RoE) of 8.37% reflects moderate profitability. Overall, the company is well-positioned for potential long-term growth, driven by its diversified health care services and international presence.

Additional Sources for CI Stock

CI Stock Overview

Market Cap in USD 89,501m
Sector Healthcare
Industry Healthcare Plans
GiC Sub-Industry Health Care Services
IPO / Inception 1982-03-31

CI Stock Ratings

Growth Rating 47.6
Fundamental 34.8
Dividend Rating 68.4
Rel. Strength -4.76
Analysts 4.4/5
Fair Price Momentum 364.97 USD
Fair Price DCF 726.14 USD

CI Dividends

Dividend Yield 12m 2.16%
Yield on Cost 5y 4.21%
Annual Growth 5y 168.67%
Payout Consistency 86.4%

CI Growth Ratios

Growth Correlation 3m 93%
Growth Correlation 12m -51.1%
Growth Correlation 5y 90.1%
CAGR 5y 14.67%
CAGR/Max DD 5y 0.52
Sharpe Ratio 12m 0.62
Alpha -9.03
Beta 0.222
Volatility 25.75%
Current Volume 1562.9k
Average Volume 20d 1645.6k
What is the price of CI stocks?
As of May 01, 2025, the stock is trading at USD 340.04 with a total of 1,562,947 shares traded.
Over the past week, the price has changed by +0.99%, over one month by +3.36%, over three months by +16.15% and over the past year by -3.12%.
Is Cigna a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cigna is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.78 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CI as of May 2025 is 364.97. This means that CI is currently overvalued and has a potential downside of 7.33%.
Is CI a buy, sell or hold?
Cigna has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy CI.
  • Strong Buy: 14
  • Buy: 7
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CI stock price target?
According to ValueRays Forecast Model, CI Cigna will be worth about 394.2 in May 2026. The stock is currently trading at 340.04. This means that the stock has a potential upside of +15.92%.
Issuer Forecast Upside
Wallstreet Target Price 363.1 6.8%
Analysts Target Price 395.7 16.4%
ValueRay Target Price 394.2 15.9%